AstraZeneca to Create Over 800 Skilled Jobs in Asia with $1.5B ADC Manufacturing Facility in Singapore

AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global supply c...

November 07, 2024 | Thursday | News
OmniActive Health Technologies Acquires ENovate Biolife to Expand Portfolio of Clinically Proven Health Ingredients

OmniActive Health Technologies (OmniActive) announced the acquisition of ENovate Biolife (ENovate), further strengthening its commitment to innovative...

November 05, 2024 | Tuesday | News
Bayer Debuts Industry-First PET Blister Packaging for Aleve, Pioneering Sustainable Change in Healthcare Packaging

Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Reali...

October 31, 2024 | Thursday | News
Ardena Expands Bioanalytical Services with New Lab in Oss, Netherlands, Enhancing Capabilities to Meet Growing Client Demand

  Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlan...

October 31, 2024 | Thursday | News
MilliporeSigma Rolls Out €70 Million Expansion to Transform St. Louis into a Hub for Advanced ADC Manufacturing and Biopharma Innovation

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | Wednesday | News
PL Developments Secures FDA Approval for Omeprazole OTC and Successfully Refinances Corporate Debt

PL Developments (PLD), a leader in the development, manufacturing, packaging, and distribution of consumer healthcare products, announced two significant m...

October 29, 2024 | Tuesday | News
GC Biopharma and Novelty Nobility Form Strategic South Korea-Based Alliance to Develop Novel Treatment for Geographic Atrophy (GA)

GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therape...

October 28, 2024 | Monday | News
Eli Lilly’s Donanemab Receives MHRA Approval for Alzheimer's Treatment in Great Britain

Eli Lilly and Company (NYSE: LLY) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization fo...

October 24, 2024 | Thursday | News
Ionis and AstraZeneca's WAINZUA Recommended for EU Approval for Hereditary Amyloidosis Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced that Ionis' and AstraZeneca's WAINZUA (eplontersen) has been recommended for approval by the Comm...

October 22, 2024 | Tuesday | News
Catalent CEO John Chiminski Issues Open Letter Addressing Novo Holdings’ Acquisition and Reaffirms Commitment to Customers

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, issued the following open lette...

October 22, 2024 | Tuesday | News
Innovent Biologics Announces Successful Phase 2 Results for Picankibart in Treating Ulcerative Colitis

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 17, 2024 | Thursday | News
AtomVie and Radiopharm Ventures Partner to Develop Targeted Radiopharmaceutical 177Lu-BetaBart

AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreeme...

October 16, 2024 | Wednesday | News
Avirmax Biopharma to Showcase Innovative Gene Therapy Advances at AAO 2024

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 20...

October 16, 2024 | Wednesday | News
Merck Opens €290 Million State-of-the-Art Biosafety Testing Facility in Maryland, Accelerating Global Drug Development

Note: Merck operates as MilliporeSigma in North America.   Facility consolidates biosafety testing, analytical development, and cell bank manufact...

October 10, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close